A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.
Phase 2
Completed
- Conditions
- Obesity
- Registration Number
- NCT00349635
- Lead Sponsor
- Solvay Pharmaceuticals
- Brief Summary
To investigate the effect on body weight of a combination fenofibrate and metformin on top of a moderate balanced calorie-deficit diet.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 148
Inclusion Criteria
- Both genders, BMI ≥ 30 kg/m² and <40 kg/m².
Exclusion Criteria
- Known abnormal thyroid hormone levels, or high thyroid stimulating hormone (TSH) level.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Weight
- Secondary Outcome Measures
Name Time Method Waist and hip circumference
Trial Locations
- Locations (3)
Site 3
🇫🇮Kuopio, Finland
Site 1
🇫🇮Helsinki, Finland
Site 2
🇫🇮Oulu, Finland